| Literature DB >> 30889919 |
Abstract
In 2005, US water intake recommendations were based on analyses of Nutrition Healthand Examination Surveys (NHANES) III data that examined if hydration classification varied bywater intake and estimated the median water intake associated with hydration in persons aged 19⁻30. Given the upcoming 2020⁻2025 Dietary Guidelines review, this analysis addresses the same twoaims with the 2009⁻2012 NHANES data. Methods were updated by defining hydration criteria interms of multiple measures (serum sodium 135⁻144 mmol/L and urine osmolality < 500 mmol/kg),expressing water intake as ml/kg, distinguishing plain water intake (PWI) from total water intake(TWI), using weighted age- and sex-specific multivariable models to control for determinants ofwater intake requirements, and selecting two study samples (non-acutely ill US population and asub-group without selected chronic disease risk factors). In the US population and sub-group, therelative risk (RR) of meeting the hydration criteria was significantly greater for individuals withTWI ≥ 45 mL/kg or PWI ≥ 20 mL/kg (for the US population 19⁻50 years of age: adjusted RR (RRrepresents Relative Risk, which is a very standard term that probably does not need to be spelledout) = 1.36, 95% CI: 1.10⁻1.68 for males; adjusted RR = 1.70, 95% CI: 1.49⁻1.95 for females. For thesub-group 51⁻70 years of age: adjusted RR = 2.20, 95% CI: 1.15⁻4.18 for males; adjusted RR = 2.00,95% CI: 1.18⁻3.40 for females). The median (SE, which stands for Standard Error, which is also verywell known. Up to you if your journal prefers to spell it out in the abstract) TWI and PWI associatedwith meeting the hydration criteria for males and females 19⁻50 years of age were 42 (2) mL/kg and14 (1) mL/kg and 43 (2) mL/kg and 16 (1) mL/kg, respectively. The significant association betweenwater intake and hydration classification differs from the null association, underlying the 2005 waterintake recommendations, and may lead to different reasoning and inferences for the 2020⁻2025Dietary Guidelines.Entities:
Keywords: drinking water; hydration; serum sodium; total water intake; urine osmolality
Mesh:
Substances:
Year: 2019 PMID: 30889919 PMCID: PMC6471100 DOI: 10.3390/nu11030657
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Characteristics of the US population aged 12–80 years in 2009–2012.
| Age 12–18 Years | Age 19–50 Years | Age 51–70 Years | Age 71–80 Years | |
|---|---|---|---|---|
| Weighted | Weighted | Weighted | Weighted | |
| Male | ( | ( | ( | ( |
| Body weight, kg | 66.8 (0.9) | 86.4 (0.5) | 89.0 (0.8) | 81.9 (0.5) |
| Height, cm | 170.0 (0.5) | 176.5 (0.3) | 175.7 (0.4) | 172.1 (0.3) |
| BMI | 23.1 (0.3) | 27.7 (0.2) | 28.8 (0.3) | 27.6 (0.2) |
| Serum Na, mmol/L | 139.4 (0.1) | 139.2 (0.1) | 139.1 (0.1) | 139.5 (0.1) |
| Urine Volume, mL | 99.3 (4.8) | 113.7 (2.9) | 100.1 (3.2) | 77.4 (2.9) |
| Urine Osmolality, mmol/kg | 721 (24) | 618 (10) | 566 (9) | 550 (8) |
| Urine Albumin:Creatinine | 7.7 (0.5) | 5.4 (0.2) | 7.9 (0.4) | 15.6 (0.9) |
| eGFR, mL/min/1.73 m2 | 135.8 (1.1) | 102.3 (0.5) | 81.5 (0.7) | 62.5 (0.9) |
| Serum Creatinine, mg/dL | 0.8 (0.01) | 0.9 (0.01) | 1.0 (0.01) | 1.1 (0.01) |
| HgA1c, % | 5.2 (0.01) | 5.4 (0.01) | 5.8 (0.03) | 5.9 (0.03) |
| Female | ( | ( | ( | ( |
| Body weight, kg | 59.4 (0.8) | 73.3 (0.5) | 74.9 (0.8) | 68.7 (0.8) |
| Height, cm | 161.0 (0.3) | 163.0 (0.3) | 161.5 (0.3) | 157.7 (0.3) |
| BMI | 22.9 (0.3) | 27.6 (0.2) | 28.7 (0.3) | 27.7 (0.3) |
| Serum Na, mmol/L | 139.2 (0.1) | 138.6 (0.1) | 139.5 (0.1) | 139.2 (0.1) |
| Urine Volume, mL | 74.3 (3.6) | 78.6 (2.1) | 73.7 (3.3) | 54.4 (2.3) |
| Urine Osmolality, mmol/kg | 620.5 (15.1) | 521.9 (12.2) | 455.2 (11.5) | 455.9 (8.9) |
| Urine Albumin:Creatinine | 12.0 (0.9) | 7.7 (0.1) | 9.0 (0.4) | 16.3 (1.0) |
| eGFR, mL/min/1.73 m2 | 128.3 (2.3) | 106.3 (0.5) | 82.9 (0.7) | 60.9 (0.9) |
| Serum Creatinine, mg/dL | 0.7 (0.01) | 0.7 (0.004) | 0.8 (0.01) | 0.9 (0.01) |
| HgA1c, % | 5.3 (0.02) | 5.3 (0.01) | 5.8 (0.02) | 5.9 (0.03) |
Data representative of the US population were obtained from the National Health and Nutrition Examination Surveys (NHANES). The study population included all participants in the 2009–2012 NHANES with data for water intake, serum sodium, and body weight. Estimates in this table are geometric means and standard errors (SE) with survey weights applied. BMI: Body mass index; eGFR: estimated glomerular function; HgA1c: Glycated hemoglobin.
Characteristics of the US population sub-group aged 12–70 years in 2009–2012 without selected chronic disease risk factors.
| Age 12–18 Years | Age 19–50 Years | Age 51–70 Years | |
|---|---|---|---|
| Weighted | Weighted | Weighted | |
| Male | ( | ( | ( |
| Body Weight, kg | 58.7 (0.9) | 69.4 (0.7) | 70.7 (1.0) |
| Height, cm | 170.6 (0.8) | 176.4 (0.5) | 176.8 (0.9) |
| BMI | 20.2 (0.2) | 22.3 (0.2) | 22.6 (0.2) |
| Serum Na, mmol/L | 139.7 (0.1) | 139.2 (0.2) | 138.9 (0.3) |
| Urine Volume, mL | 77.2 (7.6) | 110.3 (9.4) | 86.5 (15.3) |
| Urine Osmolality, mmol/kg | 731 (28) | 561 (32) | 508 (27) |
| Urine Albumin:Creatinine | 6.7 (0.6) | 5.1 (0.2) | 5.5 (0.3) |
| eGFR, mL/min/1.73 m2 | 137.3 (1.1) | 108.3 (1.3) | 86.7 (1.4) |
| Serum Creatinine, mg/dL | 0.8 (0.01) | 0.9 (0.01) | 0.9 (0.02) |
| HgA1c, % | 5.2 (0.03) | 5.3 (0.03) | 5.5 (0.04) |
| Fasting HOMA-IR | 0.8 (0.04) | 0.6 (0.03) | 0.6 (0.03) |
| Fasting Glucose, mg/dL | 93.3 (0.5) | 94.0 (0.7) | 97.1 (1.6) |
| Fasting Triglyceride, mg/dL | 57.3 (2.0) | 78.0 (2.4) | 82.8 (3.9) |
| Fasting HDL, mg/dL | 53.7 (0.7) | 55.0 (0.9) | 58.8 (2.3) |
| Female | ( | ( | ( |
| Body Weight, kg | 53.0 (0.6) | 59.8 (0.5) | 59.4 (0.8) |
| Height, cm | 161.5 (0.5) | 165.0 (0.5) | 162.7 (0.8) |
| BMI | 20.3 (0.2) | 22.0 (0.1) | 22.4 (0.2) |
| Serum Na, mmol/L | 138.9 (0.3) | 138.7 (0.1) | 139.8 (0.2) |
| Urine Volume, mL | 71.6 (9.8) | 76.5 (5.6) | 75.1 (11.0) |
| Urine Osmolality, mmol/kg | 561 (45) | 459 (22) | 382 (32) |
| Urine Albumin:Creatinine | 7.7 (0.6) | 6.5 (0.3) | 7.7 (0.4) |
| eGFR, mL/min/1.73 m2 | 128.3 (1.8) | 104.7 (1.2) | 89.4 (1.4) |
| Serum Creatinine, mg/dL | 0.7 (0.01) | 0.7 (0.01) | 0.7 (0.01) |
| HgA1c, % | 5.2 (0.03) | 5.2 (0.02) | 5.5 (0.03) |
| Fasting HOMA-IR | 0.8 (0.05) | 0.5 (0.02) | 0.5 (0.06) |
| Fasting Glucose, mg/dL | 90.8 (0.7) | 89.7 (0.5) | 95.6 (0.9) |
| Fasting Triglyceride, mg/dL | 64.0 (2.4) | 68.5 (1.5) | 83.2 (3.8) |
| Fasting HDL, mg/dL | 62.4 (0.7) | 66.0 (1.0) | 70.5 (1.9) |
Data representative of the US population were obtained from the National Health and Nutrition Examination Surveys (NHANES). The sub-group excluded participants who were older than 70 years, had not fasted for 8 hours, pregnant or lactating women, individuals who self-reported ever having a diagnosis of diabetes or weak or failing kidneys, individuals with a measured body mass index (BMI) outside the normal weight range, and individuals with fasting glycated hemoglobin (HgA1c) ≥ 6.5%, fasting Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) ≥ 2.5, fasting glucose ≥ 126 mg/dL, fasting triglyceride ≥ 150 mg/dL, fasting HDL < 40 mg/dL for men, HDL < 50 mg/dL for women, and/or estimated glomerular filtration rate (eGFR) < 60. Estimates in this table are geometric means and standard errors (SE) with survey weights applied.
Figure 1Serum sodium and urine osmolality of males and females in the US population. Each dot represents the serum sodium and urine osmolality of one NHANES 2009–2012 participant. Blue dots represent participants that had both a serum sodium values between 135–144 mmol/L and a urine osmolality below 500 mmol/kg.
Proportion of the US population and sub-group without selected chronic disease risk factors that met the hydration criteria in 2009–2012 by life-stage group.
| US Population | Sub-Group without Selected Chronic Disease Risk Factors | |||||
|---|---|---|---|---|---|---|
| Total | Met Hydration Criteria | Total | Met Hydration Criteria | |||
| Yes | No | Yes | No | |||
|
| Weighted | Weighted |
| Weighted | Weighted | |
| Male | ||||||
| 12–18 years | 978 | 16.5 (11.9–22.5) | 83.5 (77.5–88.1) | 201 | 12.8 (8.1–19.5) | 87.2 (80.5–91.8) |
| 19–50 years | 2703 | 22.7 (20.1–25.6) | 77.3 (74.4–80.0) | 234 | 29.9 (23.6–37.2) | 70.1 (62.8–76.4) |
| 51–70 years | 1551 | 27.9 (24.5–31.6) | 72.1 (68.4–75.5) | 96 | 43.2 (27.5–60.4) | 56.8 (39.6–72.5) |
| 71–80 years | 713 | 28.9 (25.7–32.4) | 71.1 (67.6–74.3) | |||
| Female | ||||||
| 12–18 years | 882 | 19.8 (15.7–24.6) | 80.2 (75.4–84.3) | 132 | 18.2 (11.5–27.5) | 81.8 (72.5–88.5) |
| 19–50 years | 2849 | 28.7 (25.6–31.9) | 71.3 (68.1–74.4) | 305 | 32.7 (26.7–39.4) | 67.3 (60.6–73.3) |
| 51–70 years | 1526 | 34.1 (29.4–39.0) | 65.9 (61.0–70.6) | 98 | 51.0 (36.0–65.8) | 49.0 (34.2–64.0) |
| 71–80 years | 722 | 30.8 (26.3–35.7) | 69.2 (64.3–73.7) | |||
| Pregnant | 108 | 24.9 (15.3–37.9) | 75.1 (62.1–84.7) | |||
Data representative of the US population were obtained from the National Health and Nutrition Examination Surveys (NHANES). The sub-group excluded participants who were older than 70 years, had not fasted for eight hours, pregnant or lactating women, individuals who self-reported ever having a diagnosis of diabetes or weak or failing kidneys, individuals with a measured BMI outside the normal weight range, and individuals with fasting HgA1c ≥ 6.5%, fasting HOMA-IR ≥ 2.5, fasting glucose ≥ 126 mg/dL, fasting triglyceride ≥ 150 mg/dL, fasting HDL < 40 mg/dL for men, HDL < 50 mg/dL for women, and/or estimated glomerular filtration rate (eGFR) < 60. Participants were classified as hydrated if they had a serum sodium of 135–144 mmol/L, a urine volume ≥ 50 mL, and a urine osmolality < 500 mmol/kg. n: Number of NHANES participants in the row category. Weighted % (95% CI): Weighted proportion of the row category who met (or did not meet) the hydration criteria with the corresponding 95% confidence interval.
Figure 2Total water intake (TWI) and plain water intake (PWI) of males and females in the study population. The figure illustrates the correlation between total water intake and plain water intake. Each dot represents the TWI and PWI of one NHANES 2009–2012 participant.
Figure 3Predicted probability of meeting hydration criteria associated with TWI at or above cutoffs ranging from 20–60 mL/kg or PWI at or above cutoffs ranging from 0–50 mL/kg for the US population and sub-group without selected chronic disease risk factors by sex and age. Participants were classified as hydrated if they had a serum sodium of 135–144 mmol/L, a urine volume ≥ 50 mL, and a urine osmolality < 500 mmol/kg. The probability of meeting the hydration criteria was predicted from weighted, age- and sex-specific logistic regression models that adjusted for age in years, body weight, solute load, race–ethnicity, level of physical activity, cigarette smoking, any prescription medication used in the past month, and season of the MEC visit. The probabilities were predicted holding each covariate at its mean for each sex and age group. See the interactive Tableau dashboard for further detail (Supplementary Figure S1).
Relative risk of meeting the hydration criteria associated with TWI ≥ 45 mL/kg or PWI ≥ 20 mL/kg for the US population aged 12–80 years in 2009–2012.
| Water Intake | Total | Percent Hydrated | Relative Risk of Meeting the Hydration Criteria | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Unadjusted | Multivariable Adjusted | ||||||||
| Model 1 | Model 2 | Model 3 | |||||||
| TWI ≥ 45 mL/kg |
| Weighted % | Weighted RR |
| Weighted RR |
| Weighted RR |
| |
| US Population | |||||||||
| Male | |||||||||
| 12–18 years | No | 683 | 12.8 (9.5–17.1) | 1.0 | 1.0 | 1.0 | |||
| Yes | 295 | 24.6 (14.6–38.3) | 1.92 (1.16–3.19)) | 0.013 | 1.77 (1.21–2.59) | 0.005 | 1.58 (1.09–2.30) | 0.018 | |
| 19–50 years | No | 1623 | 19.2 (16.2–22.6) | 1.0 | 1.0 | 1.0 | |||
| Yes | 1080 | 27.6 (23.6–31.9) | 1.43 (1.16–1.77) | 0.001 | 1.50 (1.22–1.84) | 0.000 | 1.36 (1.10–1.68) | 0.006 | |
| 51–70 years | No | 1123 | 21.8 (18.5–25.5) | 1.0 | 1.0 | 1.0 | |||
| Yes | 428 | 41.7 (33.9–49.9) | 1.91 (1.49–2.46) | 0.000 | 1.96 (1.52–2.53) | 0.000 | 1.76 (1.36–2.28) | 0.000 | |
| 71–80 years | No | 583 | 26.3 (22.4–30.7) | 1.0 | 1.0 | 1.0 | |||
| Yes | 130 | 40.8 (29.8–52.9) | 1.55 (1.06–2.26) | 0.02 | 1.48 (1.01–2.17) | 0.045 | 1.47 (0.96–2.24) | 0.074 | |
| Female | |||||||||
| 12–18 years | No | 664 | 15.4 (11.5–20.3) | 1.0 | 1.0 | 1.0 | |||
| Yes | 218 | 30.0 (22.0–39.4) | 1.94 (1.35–2.79) | 0.001 | 1.85 (1.25–2.74) | 0.003 | 1.75 (1.19–2.58) | 0.006 | |
| 19–50 years | No | 1759 | 21.2 (18.1–24.6) | 1.0 | 1.0 | 1.0 | |||
| Yes | 1090 | 39.8 (35.5–44.3) | 1.88 (1.63–2.17) | 0.000 | 1.79 (1.56–2.05) | 0.000 | 1.70 (1.49–1.95) | 0.000 | |
| 51–70 years | No | 1038 | 29.4 (24.4–35.0) | 1.0 | 1.0 | 1.0 | |||
| Yes | 488 | 42.4 (34.5–50.6) | 1.44 (1.12–1.86) | 0.006 | 1.42 (1.07–1.88) | 0.016 | 1.29 (1.00–1.66) | 0.051 | |
| 71–80 years | No | 570 | 29.3 (24.1–35.0) | 1.0 | 1.0 | 1.0 | |||
| Yes | 152 | 36.2 (27.6–45.8) | 1.24 (0.91–1.69) | 0.172 | 1.28 (0.93–1.77) | 0.128 | 1.22 (0.87–1.71) | 0.234 | |
| Pregnant | No | 62 | 15.3 (7.3–29.4) | 1.0 | 1.0 | 1.0 | |||
| Yes | 46 | 38.2 (22.7–56.5) | 2.50 (1.10–5.66) | 0.030 | 2.08 (0.87–4.93) | 0.095 | 1.78 (0.81–3.90) | 0.145 | |
| Sub-group without selected chronic disease risk factors | |||||||||
| Male | |||||||||
| 12–18 years | No | 122 | 9.7 (5.4–16.6) | 1.0 | 1.0 | 1.0 | |||
| Yes | 79 | 17.3 (8.7–31.3) | 1.79 (0.79–4.05) | 0.155 | 1.99 (0.87–4.54) | 0.098 | 1.83 (0.78–4.29) | 0.156 | |
| 19–50 years | No | 129 | 30.4 (21.4–41.1) | 1.0 | 1.0 | 1.0 | |||
| Yes | 105 | 29.4 (21.2–39.2) | 0.97 (0.62–1.51) | 0.885 | 1.18 (0.69–2.03) | 0.536 | 1.16 (0.67–1.99) | 0.587 | |
| 51–70 years | No | 65 | 30.8 (17.7–48.0) | 1.0 | 1.0 | 1.0 | |||
| Yes | 31 | 62.7 (34.3–84.4) | 2.04 (1.09–3.82) | 0.028 | 1.92 (1.07–3.46) | 0.030 | 2.20 (1.15–4.18) | 0.018 | |
| Female | |||||||||
| 12–18 years | No | 84 | 14.1 (5.5–31.5) | 1.0 | 1.0 | 1.0 | |||
| Yes | 48 | 23.9 (14.5–36.7) | 1.70 (0.57–5.07) | 0.333 | 1.97 (0.66–5.84) | 0.214 | 3.36 (1.23–9.21) | 0.020 | |
| 19–50 years | No | 158 | 24.4 (16.1–35.0) | 1.0 | 1.0 | 1.0 | |||
| Yes | 147 | 41.2 (35.5–47.2) | 1.69 (1.15–2.50) | 0.010 | 1.56 (1.04–2.35) | 0.032 | 1.56 (1.05–2.34) | 0.031 | |
| 51–70 years | No | 47 | 39.7 (21.4–61.6) | 1.0 | 1.0 | 1.0 | |||
| Yes | 51 | 61.9 (43.4–77.5) | 1.56 (0.90–2.71) | 0.112 | 1.88 (1.12–3.17) | 0.019 | 2.00 (1.18–3.40) | 0.011 | |
Data representative of the US population were obtained from the 2009–2012 National Health and Nutrition Examination Surveys (NHANES). The sub-group excluded participants who were older than 70 years, had not fasted for eight hours, pregnant or lactating women, individuals who self-reported ever having a diagnosis of diabetes or weak or failing kidneys, individuals with a measured BMI outside the normal weight range, and individuals with fasting HgA1c ≥ 6.5%, fasting HOMA-IR ≥ 2.5, fasting glucose ≥ 126 mg/dL, fasting triglyceride ≥ 150 mg/dL, fasting HDL < 40 mg/dL for men, HDL < 50 mg/dL for women, and/or estimated glomerular filtration rate (eGFR) < 60. Participants were classified as hydrated if they had a serum sodium of 135–144 mmol/L, a urine volume ≥ 50 mL, and a urine osmolality < 500 mmol/kg. n, Number of NHANES participants in the row category. Weighted % (95%CI), Weighted proportion of the row category who met the hydration criteria with corresponding 95% confidence interval. The relative risk (RR) of meeting the hydration criteria was estimated using Poisson models with robust standard errors and survey weights applied to all models. Model 1 estimated the RR of meeting the hydration criteria associated with having a total water intake (TWI) ≥ 45 mL/kg or plain water intake (PWI) ≥ 20 mL/kg without adjusting for covariates. Model 2 adjusted the RR estimate for age in years, race–ethnicity, level of physical activity METs, dietary solute load, cigarette smoking, prescription medication use, winter season, fasting status, and morning, afternoon or evening timing of the MEC visit. Model 3 added control for body weight. p, p-value.
Relative risk of meeting the hydration criteria associated with TWI ≥ 45 mL/kg and PWI ≥ 20 mL/kg for the US population aged 12–80 years in 2009–2012.
| Water Intake | Total | Percent Hydrated | Relative Risk of Meeting Hydration Criteria | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Unadjusted | Multivariable Adjusted | |||||||||
| Model 1 | Model 2 | Model 3 | ||||||||
| mL/kg |
| Weighted | Weighted |
| Weighted |
| Weighted |
| ||
| US Population | ||||||||||
| Male | 12–18 years | TWI < 45 PWI < 20 | 683 | 12.8 (9.4–17.1) | 1.0 | 1.0 | 1.0 | |||
| TWI < 45 PWI ≥ 20 | 67 | 8.7 (5.3–13.9) | 0.68 (0.40–1.15) | 0.145 | 0.61 (0.33–1.14) | 0.118 | 0.62 (0.32–1.17) | 0.135 | ||
| TWI ≥ 45 PWI < 20 | 93 | 37.5 (17.3–63.2) | 2.92 (1.51–5.66) | 0.002 | 2.83 (1.64–4.88) | 0.000 | 2.48 (1.39–4.42) | 0.003 | ||
| TWI ≥ 45 PWI ≥ 20 | 135 | 18.7 (10.2–31.6) | 1.46 (0.75–2.81) | 0.253 | 1.45 (0.72–2.90) | 0.285 | 1.33 (0.67–2.61) | 0.408 | ||
| 19–50 years | TWI < 45 PWI < 20 | 1623 | 19.2 (16.2–22.6) | 1.0 | 1.0 | 1.0 | ||||
| TWI < 45 PWI ≥ 20 | 185 | 19.6 (13.6–27.4) | 1.02 (0.69–1.51) | 0.926 | 0.97 (0.66–1.43) | 0.886 | 0.97 (0.66–1.42) | 0.867 | ||
| TWI ≥ 45 PWI < 20 | 379 | 26.6 (18.7–36.2) | 1.38 (0.98–1.94) | 0.062 | 1.50 (1.07–2.10) | 0.020 | 1.29 (0.92–1.81) | 0.129 | ||
| TWI ≥ 45 PWI ≥ 20 | 516 | 31.3 (25.7–37.6) | 1.63 (1.27–2.09) | 0.000 | 1.75 (1.38–2.22) | 0.000 | 1.58 (1.25–2.01) | 0.000 | ||
| 51–70 years | TWI < 45 PWI < 20 | 1123 | 21.8 (18.5–25.5) | 1.0 | 1.0 | 1.0 | ||||
| TWI < 45 PWI ≥ 20 | 88 | 25.7 (15.3–39.9) | 1.18 (0.69–2.01) | 0.532 | 1.18 (0.69–1.99) | 0.534 | 1.23 (0.74–2.03) | 0.414 | ||
| TWI ≥ 45 PWI < 20 | 170 | 47.5 (33.2–62.3) | 2.18 (1.55–3.07) | 0.000 | 2.31 (1.57–3.40) | 0.000 | 1.98 (1.35–2.90) | 0.001 | ||
| TWI ≥ 45 PWI ≥ 20 | 170 | 41.5 (31.3–52.3) | 1.90 (1.39–2.60) | 0.000 | 1.99 (1.48–2.69) | 0.000 | 1.80 (1.31–2.48) | 0.001 | ||
| 71–80 years | TWI < 45 PWI < 20 | 583 | 26.3 (22.4–30.7) | 1.0 | 1.0 | 1.0 | ||||
| TWI < 45 PWI ≥ 20 | 39 | 32.5 (14.6–57.6) | 1.23 (0.57–2.65) | 0.579 | 1.20 (0.61–2.37) | 0.580 | 1.21 (0.62–2.34) | 0.564 | ||
| TWI ≥ 45 PWI < 20 | 35 | 38.4 (22.0–58.0) | 1.46 (0.83–2.56) | 0.180 | 1.36 (0.78–2.35) | 0.269 | 1.34 (0.73–2.47) | 0.332 | ||
| TWI ≥ 45 PWI ≥ 20 | 56 | 49.1 (34.7–63.7) | 1.87 (1.33–2.63) | 0.001 | 1.80 (1.22–2.67) | 0.004 | 1.79 (1.15–2.79) | 0.012 | ||
| Female | 12–18 years | TWI < 45 PWI < 20 | 664 | 15.4 (11.5–20.3) | 1.0 | 1.0 | 1.0 | |||
| TWI < 45 PWI ≥20 | 55 | 20.6 (10.4–36.8) | 1.34 (0.66–2.71) | 0.408 | 1.31 (0.61–2.80) | 0.480 | 1.34 (0.63–2.84) | 0.431 | ||
| TWI ≥45 PWI < 20 | 53 | 28.3 (13.6–50.0) | 1.83 (0.85–3.93) | 0.116 | 1.85 (0.86–3.97) | 0.114 | 1.71 (0.75–3.89) | 0.191 | ||
| TWI ≥45 PWI ≥20 | 110 | 34.7 (21.3–51.1) | 2.25 (1.46–3.48) | 0.001 | 2.12 (1.27–3.53) | 0.005 | 1.99 (1.17–3.37) | 0.012 | ||
| 19–50 years | TWI < 45 PWI < 20 | 1759 | 21.2 (18.1–24.6) | 1.0 | 1.0 | 1.0 | ||||
| TWI < 45 PWI ≥20 | 290 | 28.5 (21.9–36.3) | 1.35 (1.06–1.71) | 0.016 | 1.35 (1.06–1.71) | 0.016 | 1.36 (1.06–1.73) | 0.016 | ||
| TWI ≥45 PWI < 20 | 237 | 43.7 (35.2–52.4) | 2.06 (1.67–2.55) | 0.000 | 2.04 (1.62–2.57) | 0.000 | 1.91 (1.51–2.41) | 0.000 | ||
| TWI ≥45 PWI ≥20 | 563 | 42.8 (37.0–48.7) | 2.03 (1.70–2.41) | 0.000 | 1.88 (1.59–2.22) | 0.000 | 1.79 (1.51–2.12) | 0.000 | ||
| 51–70 years | TWI < 45 PWI < 20 | 1038 | 29.4 (24.4–35.0) | 1.0 | 1.0 | 1.0 | ||||
| TWI < 45 PWI ≥20 | 128 | 33.3 (21.5–47.7) | 1.13 (0.72–1.78) | 0.585 | 1.16 (0.74–1.84) | 0.487 | 1.14 (0.72–1.78) | 0.569 | ||
| TWI ≥45 PWI < 20 | 131 | 34.2 (24.5–45.4) | 1.16 (0.83–1.62) | 0.363 | 1.13 (0.77–1.65) | 0.513 | 1.01 (0.70–1.45) | 0.957 | ||
| TWI ≥45 PWI ≥20 | 229 | 50.9 (39.9–61.7) | 1.73 (1.32–2.27) | 0.000 | 1.69 (1.27–2.27) | 0.001 | 1.52 (1.17–1.98) | 0.003 | ||
| 71–80 years | TWI < 45 PWI < 20 | 570 | 29.3 (24.1–35.0) | 1.0 | 1.0 | 1.0 | ||||
| TWI < 45 PWI ≥20 | 41 | 31.2 (19.0–46.6) | 1.07 (0.64–1.77) | 0.802 | 1.07 (0.62–1.83) | 0.813 | 1.05 (0.61–1.80) | 0.849 | ||
| TWI ≥45 PWI < 20 | 41 | 47.3 (29.1–66.3) | 1.62 (1.03–2.53) | 0.036 | 1.67 (1.00–2.79) | 0.050 | 1.56 (0.88–2.75) | 0.121 | ||
| TWI ≥45 PWI ≥20 | 70 | 32.5 (23.5–43.1) | 1.11 (0.80–1.54) | 0.514 | 1.20 (0.84–1.72) | 0.311 | 1.14 (0.80–1.63) | 0.448 | ||
| Pregnant | TWI < 45 PWI < 20 | 62 | 15.3 (7.3–29.4) | 1.0 | 1.0 | 1.0 | ||||
| TWI < 45 PWI ≥20 | 12 | 66.5 (32.2–89.2) | 4.34 (1.85–10.18) | 0.001 | 3.11 (1.13–8.57) | 0.030 | 3.22 (1.13–9.22) | 0.030 | ||
| TWI ≥45 PWI < 20 | 7 | - | - | - | - | - | - | - | ||
| TWI ≥45 PWI ≥20 | 27 | 32.2 (17.1–52.3) | 2.11 (0.83–5.34) | 0.112 | 1.95 (0.72–5.29) | 0.183 | 1.53 (0.61–3.81) | 0.350 | ||
| Sub-group without selected chronic disease risk factors | ||||||||||
| Male | 12–18 years | TWI < 45 PWI < 20 | 122 | 9.7 (5.4–16.6) | 1.0 | 1.0 | 1.0 | |||
| TWI < 45 PWI ≥20 | 13 | 20.6 (6.0–51.4) | 2.13 (0.74–6.16) | 0.156 | 1.59 (0.70–3.63) | 0.262 | 1.64 (0.71–3.82) | 0.241 | ||
| TWI ≥ 45 PWI < 20 | 26 | 20.0 (7.7–43.0) | 2.08 (0.80–5.42) | 0.130 | 2.21 (0.67–7.29) | 0.185 | 1.83 (0.56–6.04) | 0.310 | ||
| TWI ≥ 45 PWI ≥20 | 40 | 14.6 (4.07–37.5) | 1.52 (0.42–5.44) | 0.512 | 2.09 (0.61–7.13) | 0.230 | 1.96 (0.55–6.91) | 0.287 | ||
| 19–50 years | TWI < 45 PWI < 20 | 129 | 30.4 (21.4–41.1) | 1.0 | 1.0 | 1.0 | ||||
| TWI < 45 PWI ≥20 | 14 | 26.0 (6.9–62.5) | 0.85 (0.25–2.97) | 0.799 | 1.08 (0.28–4.18) | 0.914 | 1.09 (0.27–4.33) | 0.903 | ||
| TWI ≥45 PWI < 20 | 43 | 29.9 (14.3–52.2) | 0.99 (0.50–1.95) | 0.965 | 1.29 (0.62–2.67) | 0.489 | 1.26 (0.60–2.65) | 0.538 | ||
| TWI ≥ 45 PWI ≥ 20 | 48 | 30.3 (17.5–47.2) | 1.00 (0.54–1.85) | 0.995 | 1.14 (0.57–2.28) | 0.710 | 1.11 (0.56–2.17) | 0.763 | ||
| 51–70 years | TWI < 45 PWI < 20 | 65 | 30.8 (17.7–48.0) | 1.0 | 1.0 | 1.0 | ||||
| TWI < 45 PWI ≥20 | 5 | 80.7 (34.5–97.1) | 2.62 (1.30–5.27) | 0.008 | 3.21 (1.20–8.54) | 0.021 | 3.49 (1.11–11.0) | 0.034 | ||
| TWI ≥ 45 PWI < 20 | 10 | 44.4 (11.5–83.1) | 1.44 (0.50–4.19) | 0.489 | 0.98 (0.43–2.27) | 0.968 | 1.12 (0.45–2.78) | 0.797 | ||
| TWI ≥45 PWI ≥20 | 16 | 75.9 (41.0–93.4) | 2.46 (1.34–4.52) | 0.005 | 3.91 (1.59–9.62) | 0.004 | 4.21 (1.64–10.77) | 0.004 | ||
| Female | 12–18 years | TWI < 45 PWI < 20 | 84 | 14.1 (5.5–31.5) | 1.0 | 1.0 | 1.0 | |||
| TWI < 45 PWI ≥20 | 11 | 12.1 (2.0–48.3) | 0.86 (0.10–7.14) | 0.888 | 1.55 (0.20–12.10) | 0.666 | 1.71 (0.21–14.18) | 0.607 | ||
| TWI ≥45 PWI < 20 | 12 | 7.3 (2.3–21.1) | 0.52 (0.11–2.37) | 0.386 | 0.37 (0.09–1.51) | 0.161 | 0.71 (0.19–2.62) | 0.593 | ||
| TWI ≥45 PWI ≥20 | 25 | 36.6 (19.9–57.4) | 2.61 (0.92–7.38) | 0.070 | 4.40 (1.99–9.70) | 0.001 | 7.49 (2.72–20.62) | 0.000 | ||
| 19–50 years | TWI < 45 PWI < 20 | 158 | 24.4 (16.1–35.0) | 1.0 | 1.0 | 1.0 | ||||
| TWI < 45 PWI ≥20 | 21 | 27.3 (11.9–51.1) | 1.12 (0.54–2.34) | 0.757 | 1.08 (0.53–2.19) | 0.830 | 1.08 (0.53–2.21) | 0.833 | ||
| TWI ≥45 PWI < 20 | 38 | 37.3 (21.5–56.3) | 1.53 (0.83–2.81) | 0.163 | 1.38 (0.75–2.53) | 0.284 | 1.38 (0.77–2.50) | 0.272 | ||
| TWI ≥45 PWI ≥20 | 88 | 44.9 (37.1–52.9) | 1.84 (1.21–2.82) | 0.006 | 1.71 (1.10–2.68) | 0.020 | 1.71 (1.10–2.68) | 0.020 | ||
| 51–70 years | TWI < 45 PWI < 20 | 47 | 39.7 (21.3–61.6) | 1.0 | 1.0 | 1.0 | ||||
| TWI < 45 PWI ≥20 | 4 | 64.7 (13.5–95.5) | 1.63 (0.60–4.42) | 0.328 | 2.30 (0.84–6.32) | 0.102 | 2.03 (0.68–6.00) | 0.194 | ||
| TWI ≥45 PWI < 20 | 14 | 21.9 (3.9–66.0) | 0.55 (0.11–2.85) | 0.466 | 0.78 (0.17–3.59) | 0.738 | 0.80 (0.18–3.63) | 0.767 | ||
| TWI ≥45 PWI ≥20 | 33 | 71.7 (48.9–87.0) | 1.80 (1.03–3.17) | 0.041 | 2.07 (1.19–3.60) | 0.011 | 2.27 (1.34–3.86) | 0.004 | ||
Data representative of the US population were obtained from the 2009–2012 National Health and Nutrition Examination Surveys (NHANES). The sub-group excluded participants who were older than 70 years, had not fasted for eight hours, pregnant or lactating women, individuals who self-reported ever having a diagnosis of diabetes or weak or failing kidneys, individuals with a measured BMI outside the normal weight range, and individuals with fasting HgA1c ≥6.5%, fasting HOMA-IR ≥2.5, fasting glucose ≥126 mg/dL, fasting triglyceride ≥150 mg/dL, fasting HDL < 40 mg/dL for men, HDL < 50 mg/dL for women, and/or estimated glomerular filtration rate (eGFR) < 60. Participants were classified as hydrated if they had a serum sodium of 135–144 mmol/L, a urine volume ≥ 50 mL, and a urine osmolality < 500 mmol/kg. n, Number of NHANES participants in the row category. Weighted % (95%CI), Weighted proportion of the row category who met the hydration criteria with corresponding 95% confidence interval. The relative risk (RR) of meeting the hydration criteria was estimated using Poisson models with robust standard errors and survey weights applied to all models. Model 1 estimated the RR of meeting the hydration criteria without adjusting for covariates. Model 2 adjusted the RR estimate for age in years, race–ethnicity, level of physical activity METs, dietary solute load, cigarette smoking, prescription medication use, winter season, fasting status, and morning, afternoon or evening timing of the MEC visit. Model 3 added control for body weight. p, p-value.
Mean difference in TWI associated with meeting the hydration criteria versus not meeting the hydration criteria for the US population aged 12–80 years and the sub-group aged 12–70 years without selected chronic disease risk factors in 2009–2012.
| US Population | Sub-Group without Selected Chronic Disease Risk Factors | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OLS Regression Coefficients | Predicted Difference in TWI mL/kg | OLS Regression Coefficients | Predicted Difference in TWI mL/kg | |||||||||||
| Unadjusted | Multivariable Adjusted | Unadjusted | Multivariable Adjusted | |||||||||||
| Model 1 | Model 2 | Model 3 | Model 1 | Model 2 | Model 3 | |||||||||
| B (SE) |
| B (SE) |
| B (SE) |
| Mean (SE) | B (SE) |
| B (SE) |
| B (SE) |
| Mean (SE) | |
| Male | ||||||||||||||
| 12–18 years | 11.2 (4.6) | 0.020 | 8.9 (2.5) | 0.001 | 7.1 (2.3) | 0.003 | 7.1 (2.3) | 8.8 (5.2) | 0.099 | 9.5 (4.5) | 0.042 | 8.2 (4.4) | 0.069 | 8.2 (4.4) |
| 19–50 years | 5.0 (1.4) | 0.001 | 5.5 (1.2) | 0.000 | 3.5 (1.2) | 0.005 | 3.5 (1.2) | 2.7 (3.7) | 0.474 | 4.9 (3.1) | 0.130 | 4.3 (3.0) | 0.159 | 4.3 (3.0) |
| 51–70 years | 8.1 (1.8) | 0.000 | 7.7 (1.2) | 0.000 | 5.7 (1.3) | 0.000 | 5.7 (1.3) | 11.5 (9.0) | 0.212 | 10.4 (6.6) | 0.127 | 11.3 (6.6) | 0.098 | 11.3 (6.6) |
| 71–80 years | 5.6 (1.4) | 0.000 | 4.6 (1.4) | 0.002 | 4.4 (1.4) | 0.005 | 4.4 (1.4) | - | - | - | - | - | - | - |
| Female | ||||||||||||||
| 12–18 years | 6.2 (2.6) | 0.024 | 5.2 (2.2) | 0.024 | 3.9 (2.0) | 0.056 | 3.9 (2.0) | 11.9 (5.3) | 0.033 | 11.2 (5.5) | 0.050 | 14.3 (5.1) | 0.009 | 14.3 (5.1) |
| 19–50 years | 10.7 (1.2) | 0.000 | 9.6 (1.1) | 0.000 | 8.1 (0.9) | 0.000 | 8.1 (0.9) | 9.0 (3.1) | 0.006 | 7.2 (3.3) | 0.036 | 7.1 (3.2) | 0.031 | 7.1 (3.2) |
| 51–70 years | 7.4 (2.1) | 0.001 | 7.1 (2.2) | 0.003 | 5.2 (1.9) | 0.009 | 5.2 (1.9) | 7.9 (5.6) | 0.167 | 11.4 (5.0) | 0.030 | 11.8 (4.8) | 0.019 | 11.8 (4.8) |
| 71–80 years | 2.8 (1.5) | 0.064 | 3.5 (1.3) | 0.012 | 2.8 (1.2) | 0.029 | 2.8 (1.2) | - | - | - | - | - | - | - |
| Pregnant | 7.6 (4.1) | 0.075 | 5.0 (3.4) | 0.151 | 1.0 (3.3) | 0.764 | 1.0 (3.3) | - | - | - | - | - | - | - |
Data representative of the US population were obtained from the 2009–2012 National Health and Nutrition Examination Surveys (NHANES). The study population included all participants aged 12–80 years with data on water intake, serum sodium, and body weight. The sub-group excluded participants who were older than 70 years, had not fasted for 8 hours, pregnant or lactating women, individuals who self-reported ever having a diagnosis of diabetes or weak or failing kidneys, individuals with a measured BMI outside the normal weight range, and individuals with fasting HgA1c ≥ 6.5%, fasting HOMA-IR ≥ 2.5, fasting glucose ≥ 126 mg/dL, fasting triglyceride ≥ 150 mg/dL, fasting HDL < 40 mg/dL for men, HDL < 50 mg/dL for women, and/or estimated glomerular filtration rate (eGFR) < 60. Participants were classified as hydrated if they had a serum sodium of 135–144 mmol/L, a urine volume ≥ 50 mL, and a urine osmolality < 500 mmol/kg. B (SE), regression coefficient and corresponding standard error. The regression coefficients represent sex- and age-specific mean differences in total water intake (TWI) associated with meeting versus not meeting the hydration criteria, estimated by linear regression (OLS) models. Model 1 estimated the difference in TWI without adjusting for covariates. Model 2 adjusted for age in years, race–ethnicity, level of physical activity METs, dietary solute load, cigarette smoking, prescription medication use, winter season, timing of the MEC visit, and fasting status. Model 3 added control for body weight. Sex- and age-specific mean differences in TWI were predicted from Model 3, holding all covariates at their mean values. p, p-value.
Mean difference in PWI associated with meeting the hydration criteria versus not meeting the hydration criteria for the US population aged 12–80 years and the sub-group aged 12–70 years without selected chronic disease risk factors in 2009–2012.
| US Population | Sub-group without Selected Chronic Disease Risk Factors | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ZINB Model Coefficients | Predicted Difference in PWI mL/kg | ZINB Model Coefficients | Predicted Difference in PWI mL/kg | |||||||||||
| Unadjusted | Multivariable Adjusted | Unadjusted | Multivariable Adjusted | |||||||||||
| Model 1 | Model 2 | Model 3 | Model 1 | Model 2 | Model 3 | |||||||||
| B (SE) |
| B (SE) |
| B (SE) |
| Mean (SE) | B (SE) |
| B (SE) |
| B (SE) |
| Mean (SE) | |
| Male | ||||||||||||||
| 12–18 years | −0.01 (0.19) | 0.979 | 0.01 (0.18) | 0.946 | −0.02 (0.18) | 0.917 | −0.2 (2.1) | 0.23 (0.25) | 0.368 | 0.40 (0.24) | 0.101 | 0.41 (0.24) | 0.103 | 7.1 (4.6) |
| 19–50 years | 0.15 (0.06) | 0.020 | 0.16 (0.06) | 0.009 | 0.12 (0.06) | 0.035 | 1.9 (0.9) | 0.03 (0.13) | 0.815 | 0.12 (0.15) | 0.441 | 0.09 (0.15) | 0.548 | 1.4 (2.3) |
| 51–70 years | 0.24 (0.09) | 0.012 | 0.21 (0.08) | 0.015 | 0.16 (0.09) | 0.069 | 1.8 (1.0) | 0.78 (0.29) | 0.011 | 0.72 (0.24) | 0.005 | 0.73 (0.25) | 0.006 | 8.1 (3.0) |
| 71–80 years | 0.22 (0.10) | 0.040 | 0.19 (0.11) | 0.102 | 0.18 (0.11) | 0.107 | 1.6 (1.0) | - | - | - | - | - | - | - |
| Female | ||||||||||||||
| 12–18 years | 0.23 (0.09) | 0.011 | 0.22 (0.11) | 0.054 | 0.16 (0.09) | 0.081 | 2.1 (1.2) | 0.41 (0.26) | 0.131 | 0.42 (0.26) | 0.113 | 0.52 (0.19) | 0.011 | 8.7 (3.8) |
| 19–50 years | 0.29 (0.05) | 0.000 | 0.27 (0.05) | 0.000 | 0.23 (0.04) | 0.000 | 3.8 (0.7) | 0.21 (0.14) | 0.144 | 0.19 (0.15) | 0.202 | 0.20 (0.15) | 0.188 | 3.9 (3.0) |
| 51–70 years | 0.24 (0.09) | 0.010 | 0.21 (0.08) | 0.016 | 0.15 (0.07) | 0.034 | 2.0 (0.9) | 0.40 (0.18) | 0.035 | 0.53 (0.18) | 0.007 | 0.51 (0.19) | 0.010 | 9.6 (4.2) |
| 71–80 years | 0.02 (0.08) | 0.849 | 0.02 (0.07) | 0.777 | 0.00 (0.08) | 0.993 | 0.0 (0.9) | - | - | - | - | - | - | - |
| Pregnant | 0.39 (0.17) | 0.028 | 0.49 (0.18) | 0.010 | 0.49 (0.21) | 0.026 | 10.0 (4.7) | - | - | - | - | - | - | - |
Data representative of the US population were obtained from the 2009–2012 National Health and Nutrition Examination Surveys (NHANES). The study population included all participants aged 12–80 years with data on water intake, serum sodium, and body weight. The sub-group excluded participants who were older than 70 year, had not fasted for 8 hour, pregnant or lactating women, individuals who self-reported ever having a diagnosis of diabetes or weak or failing kidneys, individuals with a measured BMI outside the normal weight range, and individuals with fasting HgA1c ≥ 6.5%, fasting HOMA-IR ≥ 2.5, fasting glucose ≥ 126 mg/dL, fasting triglyceride ≥ 150 mg/dL, fasting HDL < 40 mg/dL for men, HDL < 50 mg/dL for women, and/or estimated glomerular filtration rate (eGFR) < 60. Participants were classified as hydrated if they had a serum sodium of 135–144 mmol/L, a urine volume ≥ 50 mL, and a urine osmolality < 500 mmol/kg. B (SE), regression coefficient and corresponding standard error. The regression coefficients represent the log difference in plain water intake (PWI) associated with meeting versus not meeting the hydration criteria, estimated by survey weighted zero-inflated negative binomial (ZINB) regression models. Model 1 estimated the difference in PWI without adjusting for covariates. Model 2 adjusted for age in years, race–ethnicity, level of physical activity METs, dietary solute load, cigarette smoking, prescription medication use, winter season, timing of the MEC visit, and fasting status. Model 3 added control for body weight. Sex- and age-specific mean differences in PWI were predicted from Model 3, holding all covariates at their mean values. p, p-value.
Percentiles of the TWI and PWI distributions of the US population aged 12–80 years in 2009–2012 by hydration classification and life-stage group.
| Percentiles of the TWI and PWI Distributions | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Did Not Meet Hydration Criteria | Met Hydration Criteria | |||||||||||
| 10 | 25 | 50 | 75 | 90 | 10 | 25 | 50 | 75 | 90 | |||
| Weighted Estimate (SE) | Weighted Estimate (SE) | |||||||||||
| US Population | ||||||||||||
| Male | 12–18 years | TWI, L/d | 1.2 (0.1) | 1.6 (0.1) | 2.2 (0.1) | 2.9 (0.1) | 3.9 (0.2) | 1.3 (0.1) | 1.8 (0.1) | 2.8 (0.3) | 3.5 (0.5) | 5.1 (0.4) |
| PWI, L/d | 0 | 0.1 (0.1) | 0.5 (0.04) | 1.2 (0.1) | 1.9 (0.2) | 0 | 0 | 0.4 (0.2) | 1.0 (0.4) | 2.3 (0.6) | ||
| TWI, mL/kg | 17.5 (0.8) | 23.9 (0.9) | 32.4 (1.3) | 42.7 (2.5) | 58.2 (2.5) | 21.3 (2.7) | 31.2 (2.1) | 41.5 (3.4) | 57.1 (4.7) | 74.7 (15.1) | ||
| PWI, mL/kg | 0 | 1.9 (0.9) | 8.5 (0.7) | 17.6 (1.6) | 28.6 (2.6) | 0 | 0 | 6.6 (2.2) | 17.5 (6.6) | 34.6 (7.8) | ||
| 19–50 years | TWI, L/d | 1.8 (0.05) | 2.4 (0.1) | 3.2 (0.1) | 4.3 (0.1) | 5.8 (0.2) | 1.9 (0.1) | 2.7 (0.1) | 3.5 (0.1) | 4.5 (0.1) | 5.6 (0.2) | |
| PWI, L/d | 0 | 0.2 (0.1) | 0.9 (0.1) | 1.9 (0.1) | 3.0 (0.1) | 0 | 0.4 (0.1) | 1.1 (0.1) | 2.1 (0.1) | 3.2 (0.1) | ||
| TWI, mL/kg | 20.2 (0.6) | 27.0 (0.6) | 36.6 (0.8) | 48.8 (1.4) | 67.0 (2.5) | 23.3 (0.9) | 31.7 (1.4) | 41.9 (1.6) | 55.6 (1.9) | 73.4 (2.9) | ||
| PWI, mL/kg | 0 | 2.7 (0.9) | 10.0 (0.6) | 20.8 (1.1) | 33.9 (1.2) | 0 | 4.4 (0.7) | 13.7 (1.1) | 25.4 (0.8) | 39.9 (2.5) | ||
| 51–70 years | TWI, L/d | 1.7 (0.1) | 2.3 (0.1) | 2.9 (0.1) | 4.0 (0.2) | 5.0 (0.2) | 1.9 (0.1) | 2.6 (0.1) | 3.4 (0.1) | 4.3 (0.3) | 5.6 (0.5) | |
| PWI, L/d | 0 | 0.1 (0.05) | 0.6 (0.1) | 1.4 (0.1) | 2.1 (0.2) | 0 | 0.1 (0.1) | 0.7 (0.1) | 1.6 (0.1) | 2.6 (0.4) | ||
| TWI, mL/kg | 18.2 (0.7) | 24.6 (0.6) | 32.8 (1.1) | 42.3 (1.2) | 55.5 (2.1) | 22.9 (1.1) | 29.1 (1.4) | 41.5 (1.4) | 51.1 (2.4) | 67.8 (6.2) | ||
| PWI, mL/kg | 0 | 0.7 (0.5) | 6.6 (0.7) | 15.4 (1.1) | 24.6 (1.1) | 0 | 1.5 (0.7) | 8.5 (1.3) | 19.3 (1.9) | 30.3 (5.4) | ||
| 71–80 years | TWI, L/d | 1.3 (0.04) | 1.7 (0.05) | 2.2 (0.1) | 3.0 (0.1) | 3.7 (0.2) | 1.7 (0.1) | 1.9 (0.1) | 2.5 (0.1) | 3.3 (0.2) | 4.2 (0.2) | |
| PWI, L/d | 0 | 0.01 (0.03) | 0.5 (0.04) | 0.9 (0.04) | 1.7 (0.1) | 0 | 0.2 (0.1) | 0.6 (0.1) | 1.2 (0.1) | 1.9 (0.2) | ||
| TWI, mL/kg | 15.2 (40.8) | 20.0 (0.6) | 26.7 (0.9) | 35.7 (0.9) | 45.1 (1.7) | 18.5 (1.5) | 24.5 (1.1) | 31.6 (1.5) | 42.2 (2.2) | 52.3 (4.7) | ||
| PWI, mL/kg | 0 | 0.2 (0.4) | 5.2 (0.5) | 11.1 (0.9) | 19.7 (1.0) | 0 | 2.4 (0.9) | 7.2 (1.1) | 13.4 (1.8) | 24.2 (1.9) | ||
| Female | 12–18 years | TWI, L/d | 0.9 (0.04) | 1.3 (0.1) | 1.8 (0.1) | 2.4 (0.1) | 3.0 (0.1) | 1.0 (0.1) | 1.3 (0.1) | 2.1 (0.2) | 2.9 (0.3) | 3.7 (0.6) |
| PWI, L/d | 0 | 0.1 (0.1) | 0.5 (0.01) | 1.0 (0.1) | 1.8 (0.2) | 0 | 0.2 (0.1) | 0.7 (0.1) | 1.4 (0.2) | 2.1 (0.3) | ||
| TWI, mL/kg | 14.8 (0.6) | 20.0 (1.0) | 30.3 (1.3) | 42.8 (2.0) | 51.2 (3.1) | 17.2 (1.5) | 22.9 (2.6) | 34.9 (5.3) | 53.2 (4.8) | 60.9 (3.6) | ||
| PWI, mL/kg | 0 | 1.5 (0.8) | 9.2 (0.5) | 16.2 (1.7) | 29.0 (3.9) | 0 | 2.7 (2.0) | 11.0 (2.5) | 27.1 (3.3) | 32.2 (1.8) | ||
| 19–50 years | TWI, L/d | 1.4 (0.03) | 1.8 (0.03) | 2.5 (0.04) | 3.3 (0.1) | 4.2 (0.1) | 1.7 (0.1) | 2.2 (0.1) | 3.0 (0.1) | 4.0 (0.1) | 5.2 (0.2) | |
| PWI, L/d | 0 | 0.2 (0.04) | 0.8 (0.04) | 1.6 (0.1) | 2.5 (0.1) | 0 | 0.5 (0.1) | 1.2 (0.1) | 2.0 (0.2) | 3.0 (0.2) | ||
| TWI, mL/kg | 17.5 (0.4) | 23.2 (0.6) | 33.2 (0.7) | 44.9 (0.8) | 58.4 (1.1) | 23.3 (1.0) | 30.4 (1.1) | 42.5 (1.5) | 60.5 (2.5) | 78.7 (3.0) | ||
| PWI, mL/kg | 0 | 3.0 (0.5) | 10.2 (0.6) | 21.5 (1.1) | 32.9 (1.3) | 0 | 6.7 (0.7) | 16.2 (1.3) | 29.6 (1.7) | 45.6 (2.4) | ||
| 51–70 years | TWI, L/d | 1.4 (0.1) | 1.9 (0.03) | 2.5 (0.04) | 3.4 (0.1) | 4.3 (0.1) | 1.6 (0.1) | 2.1 (0.1) | 2.7 (0.1) | 3.6 (0.2) | 4.6 (0.3) | |
| PWI, L/d | 0 | 0.2 (0.05) | 0.7 (0.1) | 1.4 (0.1) | 2.1 (0.1) | 0 | 0.3 (0.1) | 0.9 (0.1) | 1.7 (0.1) | 2.2 (0.2) | ||
| TWI, mL/kg | 18.4 (0.6) | 23.4 (0.4) | 32.3 (0.6) | 44.7 (1.4) | 57.4 (2.7) | 20.3 (1.6) | 29.0 (1.2) | 39.8 (1.7) | 52.4 (2.5) | 70.3 (7.4) | ||
| PWI, mL/kg | 0 | 2.9 (0.5) | 10.0 (0.7) | 17.8 (0.8) | 27.3 (1.6) | 0 | 3.9 (0.9) | 13.5 (1.9) | 23.3 (2.3) | 33.7 (2.3) | ||
| 71–80 years | TWI, L/d | 1.1 (0.03) | 1.5 (0.1) | 2.1 (0.1) | 2.7 (0.1) | 3.3 (0.1) | 1.3 (0.1) | 1.7 (0.1) | 2.2 (0.1) | 2.8 (0.2) | 3.5 (0.2) | |
| PWI, L/d | 0 | 0.2 (0.05) | 0.6 (0.1) | 1.1 (0.1) | 1.6 (0.1) | 0 | 0.2 (0.1) | 0.5 (0.03) | 1.0 (0.1) | 1.6 (0.1) | ||
| TWI, mL/kg | 16.6 (0.9) | 21.9 (0.8) | 30.1 (0.8) | 38.3 (1.2) | 48.7 (0.8) | 18.1 (1.2) | 23.9 (0.9) | 32.1 (2.0) | 42.2 (2.0) | 56.2 (2.1) | ||
| PWI, mL/kg | 0 | 2.9 (0.8) | 8.4 (0.8) | 15.0 (0.7) | 24.3 (1.4) | 0 | 2.9 (1.0) | 8.2 (0.6) | 14.2 (1.7) | 26.0 (2.7) | ||
| Pregnant | TWI, L/d | 1.5 (0.2) | 2.3 (0.1) | 2.8 (0.2) | 4.0 (0.2) | 4.8 (0.3) | 2.3 (0.3) | 2.8 (0.4) | 3.2 (0.2) | 3.7 (0.7) | 4.7 (0.5) | |
| PWI, L/d | 0.1 (0.1) | 0.5 (0.1) | 1.0 (0.2) | 2.3 (0.4) | 3.0 (0.6) | 0.5 (0.1) | 1.0 (0.4) | 1.8 (0.4) | 2.7 (0.5) | 3.6 (0.4) | ||
| TWI, mL/kg | 15.3 (3.9) | 23.7 (2.4) | 37.3 (2.9) | 52.7 (3.8) | 64.7 (6.3) | 23.7 (3.6) | 35.4 (5.0) | 42.0 (4.6) | 53.7 (12.5) | 60.5 (5.6) | ||
| PWI, mL/kg | 0.9 (0.8) | 5.3 (1.5) | 10.8 (2.0) | 25.8 (5.3) | 40.2 (5.7) | 5.7 (2.2) | 12.6 (4.9) | 25.1 (6.4) | 38.0 (8.8) | 45.6 (3.8) | ||
| Sub-group without selected chronic disease risk factors | ||||||||||||
| Male | 12–18 years | TWI, L/d | 1.1 (0.1) | 1.5 (0.1) | 2.1 (0.2) | 2.9 (0.1) | 3.8 (0.8) | 1.6 (0.2) | 1.9 (0.3) | 2.6 (0.2) | 3.0 (0.8) | 5.0 (1.0) |
| PWI, L/d | 0 | 0.1 (0.1) | 0.7 (0.1) | 1.3 (0.2) | 2.1 (1.2) | 0 | 0 | 0.6 (0.4) | 1.8 (0.9) | 2.8 (0.2) | ||
| TWI, mL/kg | 20.0 (1.3) | 25.8 (1.1) | 35.2 (1.7) | 50.0 (2.3) | 60.6 (8.1) | 24.5 (4.4) | 34.1 (4.7) | 43.9 (6.2) | 60.4 (8.4) | 79.6 (9.6) | ||
| PWI, mL/kg | 0 | 3.0 (1.6) | 11.9 (2.1) | 21.7 (2.9) | 33.4 (9.5) | 0 | 0 | 10.0 (6.6) | 31.8 (14.1) | 42.3 (3.0) | ||
| 19–50 years | TWI, L/d | 1.5 (0.1) | 2.2 (0.2) | 2.8 (0.1) | 3.6 (0.2) | 4.5 (0.6) | 1.6 (0.1) | 2.1 (0.2) | 2.9 (0.2) | 4.0 (0.3) | 4.9 (0.5) | |
| PWI, L/d | 0 | 0.1 (0.1) | 0.7 (0.1) | 1.6 (0.2) | 2.2 (0.3) | 0 | 0.4 (0.1) | 0.9 (0.1) | 1.5 (0.3) | 2.4 (0.5) | ||
| TWI, mL/kg | 21.8 (2.4) | 30.0 (1.8) | 40.2 (2.0) | 49.3 (2.7) | 67.2 (6.9) | 23.9 (2.5) | 31.9 (2.8) | 39.7 (3.6) | 51.8 (7.1) | 73.9 (19.0) | ||
| PWI, mL/kg | 0 | 1.8 (1.2) | 9.4 (1.2) | 22.2 (3.0) | 35.2 (6.8) | 0 | 6.2 (2.1) | 13.6 (1.7) | 20.6 (3.8) | 33.4 (7.1) | ||
| 51–70 years | TWI, L/d | 1.8 (0.3) | 2.1 (0.1) | 2.6 (0.2) | 3.1 (0.2) | 4.3 (0.4) | 1.9 (0.3) | 2.3 (0.2) | 2.8 (0.4) | 3.9 (1.5) | 7.7 (1.9) | |
| PWI, L/d | 0 | 0 | 0.2 (0.1) | 0.6 (0.2) | 1.3 (0.3) | 0 | 0.4 (0.2) | 1.2 (0.4) | 1.9 (0.4) | 3.8 (1.0) | ||
| TWI, mL/kg | 27.0 (3.9) | 31.2 (2.3) | 35.9 (3.2) | 44.7 (5.5) | 61.4 (8.7) | 23.7 (4.3) | 31.1 (3.5) | 41.9 (4.2) | 64.0 (13.1) | 108.8 (22.4) | ||
| PWI, mL/kg | 0 | 0 | 3.6 (2.2) | 9.3 (2.9) | 17.8 (5.6) | 0 | 6.4 (3.6) | 14.3 (5.2) | 25.4 (5.6) | 45.5 (10.2) | ||
| Female | 12–18 years | TWI, L/d | 1.0 (0.1) | 1.5 (0.1) | 1.9 (0.1) | 2.5 (0.3) | 3.2 (0.2) | 1.1 (0.1) | 1.5 (0.4) | 2.5 (0.4) | 3.7 (0.9) | 4.4 (0.3) |
| PWI, L/d | 0 | 0 | 0.5 (0.1) | 1.1 (0.1) | 1.6 (0.3) | 0 | 0 | 0.7 (0.5) | 1.9 (1.1) | 2.8 (0.5) | ||
| TWI, mL/kg | 21.2 (1.7) | 26.9 (1.6) | 34.3 (3.6) | 49.5 (5.4) | 58.8 (4.8) | 23.2 (3.6) | 30.7 (6.0) | 47.7 (10.9) | 65.3 (12.8) | 77.7 (6.2) | ||
| PWI, mL/kg | 0 | 0 | 10.3 (2.2) | 19.5 (2.4) | 31.3 (6.3) | 0 | 0 | 16.6 (10.0) | 36.7 (21.1) | 45.9 (4.6) | ||
| 19–50 years | TWI, L/d | 1.4 (0.1) | 1.8 (0.1) | 2.4 (0.1) | 3.3 (0.2) | 4.2 (0.4) | 1.6 (0.2) | 2.0 (0.1) | 3.0 (0.4) | 4.4 (0.2) | 4.9 (0.2) | |
| PWI, L/d | 0 | 0.3 (0.1) | 0.8 (0.1) | 1.5 (0.1) | 2.2 (0.2) | 0 | 0.4 (0.1) | 1.2 (0.2) | 2.1 (0.2) | 3.0 (0.4) | ||
| TWI, mL/kg | 23.9 (1.4) | 29.5 (1.1) | 38.4 (1.9) | 54.0 (2.8) | 72.1 (4.6) | 27.0 (3.1) | 33.8 (3.0) | 48.3 (6.0) | 70.8 (2.9) | 82.8 (3.3) | ||
| PWI, mL/kg | 0 | 5.3 (1.5) | 12.2 (1.5) | 25.3 (2.5) | 37.2 (3.2) | 0 | 5.8 (1.9) | 19.0 (3.5) | 33.7 (3.7) | 47.3 (5.4) | ||
| 51–70 years | TWI, L/d | 1.3 (0.1) | 1.8 (0.2) | 2.2 (0.2) | 3.0 (0.3) | 4.3 (0.5) | 1.5 (0.2) | 1.9 (0.3) | 2.7 (0.3) | 3.8 (0.5) | 4.8 (0.5) | |
| PWI, L/d | 0 | 0 | 0.7 (0.2) | 1.2 (0.1) | 2.1 (0.7) | 0 | 0.4 (0.3) | 1.3 (0.4) | 2.2 (0.4) | 3.1 (0.5) | ||
| TWI, mL/kg | 23.7 (3.1) | 31.1 (2.3) | 37.7 (3.3) | 52.1 (4.6) | 70.1 (7.3) | 23.4 (4.2) | 31.8 (5.9) | 45.9 (4.8) | 68.2 (7.5) | 78.2 (5.0) | ||
| PWI, mL/kg | 0 | 0 | 12.6 (3.4) | 20.0 (3.3) | 34.9 (10.1) | 0 | 6.5 (5.3) | 22.7 (6.0) | 37.7 (7.8) | 51.5 (6.9) | ||
Data representative of the US population were obtained from the 2009–2012 National Health and Nutrition Examination Surveys (NHANES). The study population included all participants aged 12–80 years with data on water intake, serum sodium, and body weight. The sub-group excluded participants who were older than 70 years, had not fasted for 8 hours, pregnant or lactating women, individuals who self-reported ever having a diagnosis of diabetes or weak or failing kidneys, individuals with a measured BMI outside the normal weight range, and individuals with fasting HgA1c ≥ 6.5%, fasting HOMA-IR ≥ 2.5, fasting glucose ≥ 126 mg/dL, fasting triglyceride ≥ 150 mg/dL, fasting HDL < 40 mg/dL for men, HDL < 50 mg/dL for women, and/or estimated glomerular filtration rate (eGFR) < 60. Participants were classified as hydrated if they had a serum sodium of 135–144 mmol/L, a urine volume ≥ 50 mL, and a urine osmolality < 500 mmol/kg. The percentiles of total water intake (TWI) and plain water intake (PWI) and corresponding standard errors (SE) were estimated with survey weights applied.
Figure 4Relationship between TWI and PWI for US males and females who met the hydration criteria in 2009–2012. Each dot represents the total water intake (TWI) and plain water intake (PWI) of one NHANES 2009–2012 participant.
Determinants of water intake requirements for the US population aged 12–80 years in 2009–2012.
| Age 12–18 years | Age 19–50 years | Age 51–70 years | Age 71–80 years | Pregnant | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Weighted |
| Weighted |
| Weighted |
| Weighted |
| Weighted% | ||
| US Population | |||||||||||
| Male | 978 | 2703 | 1551 | 713 | - | ||||||
| Body weight, kg | <70 | 574 | 56.4 (2.8) | 520 | 15.4 (1.2) | 264 | 11.1 (1.3) | 155 | 19.1 (1.7) | - | - |
| 70–79 | 180 | 17.8 (1.7) | 595 | 21.2 (1.2) | 315 | 17.8 (1.3) | 184 | 25.7 (2.1) | - | - | |
| 80–94 | 126 | 16.6 (1.7) | 818 | 33.4 (1.5 | 498 | 34.8 (2.6) | 232 | 35.7 (1.9) | - | - | |
| ≥95 | 98 | 9.2 (1.3) | 770 | 30.0 (1.2) | 474 | 36.2 (2.3) | 142 | 19.5 (1.7) | - | - | |
| Race–ethnicity | White | 283 | 55.9 (3.9) | 1092 | 62.6 (2.7) | 634 | 76.2 (2.4) | 479 | 81.5 (2.5) | - | - |
| Hispanic | 336 | 22.3 (2.9) | 746 | 18.8 (2.4) | 399 | 8.8 (1.6) | 81 | 6.4 (1.4) | - | - | |
| Black | 240 | 13.2 (1.9) | 530 | 10.9 (1.2) | 389 | 9.4 (1.3) | 107 | 7.4 (1.4) | - | - | |
| Other | 119 | 8.5 (1.9) | 335 | 7.8 (0.8) | 129 | 5.6 (0.9) | 46 | 4.7 (1.1) | - | - | |
| Activity METs, min/week | <1000 | 210 | 19.9 (2.2) | 789 | 25.9 (1.5) | 763 | 42.9 (1.7) | 457 | 61.5 (2.3) | - | - |
| 1000–4999 | 492 | 49.9 (3.2) | 939 | 37.0 (1.6) | 470 | 35.4 (1.6) | 192 | 29.5 (2.3) | - | - | |
| ≥5000 | 276 | 30.2 (3.6) | 975 | 37.1 (1.9) | 318 | 21.7 (1.8) | 64 | 9.0 (1.6) | - | - | |
| Dietary solute, mOsm/day | <500 | 253 | 24.2 (2.5) | 391 | 13.1 (0.6) | 326 | 15.9 (1.6) | 212 | 24.1 (2.1) | - | - |
| 500–999 | 528 | 52.4 (2.4) | 1479 | 54.4 (1.3) | 910 | 60.0 (1.9) | 447 | 68.5 (1.9) | - | - | |
| 1000–1499 | 163 | 19.1 (2.8) | 667 | 25.7 (1.2) | 269 | 20.7 (1.5) | 50 | 7.0 (1.2) | - | - | |
| ≥1500 | 34 | 4.3 (0.9) | 166 | 6.8 (0.8) | 46 | 3.4 (0.7) | 4 | 0.4 (0.2) | - | - | |
| Current cigarette smoker | Yes | - | - | 742 | 24.6 (1.6) | 369 | 21.8 (1.8) | 66 | 7.1 (0.9) | - | - |
| No | - | - | 1810 | 71.5 (1.3) | 1182 | 78.2 (1.8) | 647 | 92.9 (0.9) | - | - | |
| Unknown | 978 | 100 | 151 | 3.9 (0.7) | 0 | 0 | 0 | 0 | - | - | |
| Prescription medication | Yes | 202 | 22.5 (1.9) | 788 | 33.8 (1.4) | 1072 | 72.4 (1.6) | 641 | 89.6 (1.5) | - | - |
| No | 776 | 77.5 (1.9) | 1915 | 66.2 (1.4) | 479 | 27.6 (1.6) | 72 | 10.4 (1.5) | - | - | |
| MEC visit timing | Winter | 482 | 43.4 (5.7) | 1270 | 44.3 (4.7) | 735 | 37.9 (4.6) | 299 | 42.8 (6.1) | - | - |
| Summer | 496 | 56.6 (5.7) | 1433 | 55.7 (4.7) | 816 | 62.1 (4.6) | 414 | 57.2 (6.1) | - | - | |
| 8-hour fasted | Yes | 462 | 43.0 (2.9) | 1252 | 42.1 (1.9) | 726 | 45.1 (2.1) | 307 | 43.6 (2.1) | - | - |
| No | 516 | 57.0 (2.9) | 1451 | 57.9 (1.9) | 825 | 54.9 (2.1) | 406 | 56.4 (2.1) | - | - | |
| One or more chronic | Yes | 229 | 48.7 (3.1) | 1012 | 81.1 (1.8) | 623 | 85.4 (1.5) | 277 | 89.4 (2.7) | - | - |
| No | 233 | 51.3 (3.1) | 240 | 18.9 (1.8) | 101 | 14.6 (1.5) | 28 | 10.6 (2.7) | - | - | |
| Female | 882 | 2849 | 1526 | 722 | 108 | ||||||
| Body weight, kg | <60 | 483 | 57.0 (2.3) | 658 | 22.2 (1.1) | 249 | 18.4 (1.6) | 208 | 27.2 (2.0) | 17 | 12.7 (4.0) |
| 60–69 | 184 | 20.8 (2.2) | 659 | 24.5 (1.0) | 318 | 24.1 (2.4) | 196 | 29.5 (2.1) | 23 | 19.8 (5.7) | |
| 70–84 | 133 | 13.7 (1.9) | 739 | 27.0 (1.6) | 478 | 27.7 (1.6) | 180 | 24.4 (1.8) | 28 | 27.8 (4.9) | |
| ≥85 | 82 | 8.4 (1.1) | 793 | 26.3 (1.1) | 481 | 29.8 (1.8) | 138 | 18.8 (1.6) | 40 | 39.7 (6.0) | |
| Race-ethnicity | White | 243 | 59.5 (3.3) | 1151 | 60.9 (3.3) | 591 | 74.0 (2.5) | 488 | 82.8 (2.0) | 36 | 55.4 (6.3) |
| Hispanic | 316 | 20.3 (2.4) | 773 | 17.4 (2.4) | 424 | 9.5 (1.7) | 96 | 6.2 (1.3) | 31 | 20.8 (5.3) | |
| Black | 207 | 12.5 (1.8) | 604 | 13.4 (1.6) | 391 | 11.4 (1.6). | 105 | 6.6 (1.0) | 27 | 14.0 (3.1) | |
| Other | 116 | 7.8 (1.2) | 321 | 8.3 (0.8) | 120 | 5.2 (0.8) | 33 | 4.4 (0.9) | 14 | 9.7 (3.3) | |
| Activity METs, min/wk | <1000 | 385 | 38.4 (2.1) | 1430 | 47.4 (1.9) | 972 | 58.5 (2.0) | 551 | 72.2 (2.2) | 73 | 64.9 (6.6) |
| 1000–4999 | 390 | 47.4 (2.4) | 985 | 47.4 (1.9) | 405 | 32.3 (1.7) | 140 | 22.6 (2.1) | 24 | 26.3 (5.7) | |
| ≥5000 | 107 | 14.2 (2.3) | 434 | 16.2 (1.1) | 149 | 9.2 (0.9 | 31 | 5.2 (1.0) | 11 | 8.8 (4.4) | |
| Dietary solute, mOsm/d | <500 | 398 | 46.0 (2.5) | 1040 | 37.1 (1.1) | 631 | 38.4 (1.9) | 394 | 51.5 (2.1) | 23 | 24.1 (6.4) |
| 500–999 | 441 | 50.6 (2.5) | 1601 | 56.9 (1.4) | 825 | 58.1 (1.9) | 309 | 45.7 (1.9) | 73 | 67.6 (5.5) | |
| 1000–1499 | 40 | 2.7 (0.8) | 194 | 3.3 (0.6) | 67 | 5.6 (0.7) | 17 | 3.2 (0.8) | 11 | 7.3 (3.2) | |
| ≥1500 | 3 | 0.2 (0.1) | 14 | 0.4 (0.1) | 3 | 0.1 (0.0) | 2 | 0.1 (0.0) | 1 | 1.0 (1.0) | |
| Current cigarette smoker | Yes | - | - | 599 | 21.7 (1.4) | 226 | 14.5 (1.4) | 40 | 5.6 (0.9) | 15 | 10.7 (3.0) |
| No | - | - | 2136 | 75.5 (1.4) | 1300 | 85.5 (1.4) | 682 | 94.4(0.9) | 93 | 89.3 (3.0) | |
| Unknown | 882 | 100 | 114 | 2.8 (0.5) | 0 | 0 | 0 | 0 | 0 | 0 | |
| Prescription medication | Yes | 215 | 27.9 (2.9) | 1300 | 51.8 (1.9) | 1172 | 76.6 (1.3) | 671 | 92.9 (1.1) | 27 | 29.5 (6.7) |
| No | 667 | 72.1 (2.9) | 1549 | 48.2 (1.9) | 354 | 23.4 (1.3) | 51 | 7.1 (1.1) | 81 | 70.5 (6.7) | |
| MEC visit timing | Winter | 437 | 38.6 (5.3) | 1463 | 45.7 (4.6) | 811 | 39.2 (5.1) | 412 | 41.9 (5.5) | 47 | 36.7 (7.4) |
| Summer | 445 | 61.4 (5.3) | 1386 | 54.3(4.6) | 715 | 60.8 (5.1) | 310 | 58.1(5.5) | 61 | 63.3 (7.4) | |
| 8-hour fasted | Yes | 421 | 44.1 (4.1) | 1341 | 41.4 (1.4) | 757 | 47.5 (1.5) | 338 | 46.6 (2.0) | 46 | 30.8 (5.2) |
| No | 461 | 55.9 (4.1) | 1508 | 58.6 (1.4) | 769 | 52.5 (1.5) | 384 | 53.4 (2.0) | 62 | 69.2 (5.2) | |
| One or more chronic | Yes | 242 | 54.4 (3.7) | 988 | 70.4 (2.1) | 643 | 81.3 (1.6) | 288 | 84.9 (2.2) | 37 | 89.2 (4.2) |
| No | 179 | 45.6 (3.7) | 353 | 29.6 (2.1) | 114 | 18.7 (1.6) | 50 | 15.1(2.2) | 9 | 10.8 (4.2) | |
| Sub-group without selected chronic disease risk factors | |||||||||||
| Male | 201 | 234 | 96 | - | - | ||||||
| Body weight, kg | <70 | 168 | 84.2 (3.8) | 140 | 51.9 (4.5) | 55 | 41.0 (7.7) | - | - | - | - |
| 70–79 | 32 | 14.8 (3.5) | 74 | 35.8 (4.3) | 30 | 45.4 (6.7) | - | - | - | - | |
| 80–94 | 1 | 1.0 (1.0) | 20 | 12.3 (3.0) | 11 | 13.6 (5.5) | - | - | - | - | |
| ≥95 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | |
| Race–ethnicity | White | 60 | 57.1 (4.7) | 89 | 62.3 (4.4) | 40 | 72.4 (4.9) | - | - | - | - |
| Hispanic | 60 | 18.9 (3.2) | 50 | 13.1 (2.6) | 19 | 6.4 (1.9) | - | - | - | - | |
| Black | 55 | 16.7 (2.9) | 47 | 13.7 (2.6) | 23 | 13.1 (3.4) | - | - | - | - | |
| Other | 26 | 7.3 (1.9) | 48 | 11.0 (2.7) | 14 | 8.1 (3.6) | - | - | - | - | |
| Activity METs, min/wk | <1000 | 35 | 15.3 (4.3) | 66 | 28.7 (2.7) | 41 | 30.0 (5.5) | - | - | - | - |
| 1000–4999 | 110 | 56.3 (5.3) | 76 | 29.9 (3.5) | 27 | 37.0 (7.2) | - | - | - | - | |
| ≥5000 | 56 | 28.4 (5.2) | 92 | 41.3 (4.0) | 28 | 33.0 (8.3) | - | - | - | - | |
| Dietary solute, mOsm/d | <500 | 54 | 29.3 (5.1) | 30 | 14.1 (4.0) | 17 | 15.2 (4.6) | - | - | - | - |
| 500–999 | 111 | 55.8 (4.7) | 144 | 57.1 (4.2) | 56 | 58.9 (6.8) | - | - | - | - | |
| 1000–1499 | 34 | 14.3 (2.7) | 51 | 24.7 (4.1) | 21 | 23.6 (5.0) | - | - | - | - | |
| ≥1500 | 2 | 0.7 (0.5) | 9 | 4.2 (1.7) | 2 | 2.2 (1.8) | - | - | - | - | |
| Current cigarette smoker | Yes | - | 66 | 26.7 (3.9) | 24 | 29.7 (7.9) | - | - | - | - | |
| No | - | 139 | 64.6 (3.8) | 72 | 70.3 (7.9) | - | - | - | - | ||
| Unknown | 201 | 100 | 29 | 8.7 (2.0) | 0 | 0 | - | - | - | - | |
| Prescription medication | Yes | 38 | 15.7 (3.4) | 38 | 19.9 (3.2) | 59 | 75.5 (4.6) | - | - | - | - |
| No | 163 | 84.3 (3.4) | 196 | 80.1 (3.2) | 37 | 24.5 (4.6) | - | - | - | - | |
| MEC visit timing | Winter | 95 | 43.0 (6.3) | 115 | 45.3 (6.8) | 43 | 38.4 (7.5) | - | - | - | - |
| Summer | 106 | 57.0 (6.3) | 119 | 54.7 (6.8) | 53 | 61.6 (7.5) | - | - | - | - | |
| Female | 132 | 305 | 98 | - | - | ||||||
| Body weight, kg | <70 | 116 | 83.2 (4.3) | 166 | 44.9 (4.1) | 60 | 49.5 (6.5) | - | - | - | - |
| 70–79 | 15 | 16.4 (4.3) | 127 | 49.4 (4.5) | 37 | 48.9 (6.7) | - | - | - | - | |
| 80–94 | 1 | 0.4 (0.4) | 12 | 5.7 (2.0) | 1 | 1.6 (1.6) | - | - | - | - | |
| ≥95 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | |
| Race–ethnicity | White | 47 | 65.3 (5.2) | 139 | 69.4 (4.2) | 52 | 82.1 (3.8) | - | - | - | - |
| Hispanic | 40 | 15.9 (3.7) | 68 | 10.7 (1.8) | 13 | 3.5 (1.0) | - | - | - | - | |
| Black | 28 | 11.4 (3.1) | 40 | 7.2 (1.6) | 16 | 6.2 (1.8) | - | - | - | - | |
| Other | 17 | 7.4 (2.6) | 58 | 12.7 (2.7) | 17 | 8.3 (3.4) | - | - | - | - | |
| Activity METs, min/wk | <1000 | 48 | 26.7 (5.0) | 120 | 32.9 (2.5) | 51 | 40.3 (6.5) | - | - | - | - |
| 1000–4999 | 65 | 54.5 (5.4) | 130 | 47.4 (3.9) | 39 | 53.3 (7.3) | - | - | - | - | |
| ≥5000 | 19 | 18.8 (4.2) | 55 | 20.0 (2.8) | 8 | 6.3 (2.8) | - | - | - | - | |
| Dietary solute, mOsm/d | <500 | 55 | 39.4 (5.0) | 99 | 29.2 (2.9) | 44 | 39.1 (5.6) | - | - | - | - |
| 500–999 | 69 | 56.5 (5.0) | 185 | 65.1 (3.5) | 46 | 54.4 (6.0) | - | - | - | - | |
| 1000–1499 | 8 | 4.1 (1.9) | 20 | 5.5 (1.4) | 8 | 6.5 (1.6) | - | - | - | - | |
| ≥1500 | 0 | 0 | 1 | 0.2 (0.2) | 0 | 0 | - | - | - | - | |
| Current cigarette smoker | Yes | - | - | 39 | 14.3 (2.6) | 12 | 13.1 (6.2) | - | - | - | - |
| No | - | - | 249 | 83.2 (3.1) | 86 | 86.9 (6.2) | - | - | - | - | |
| Unknown | 132 | 100 | 17 | 2.4 (0.9) | 0 | 0 | - | - | - | - | |
| Prescription medication | Yes | 38 | 33.6 (6.2) | 130 | 52.1 (3.3) | 68 | 72.8 (7.1) | - | - | - | - |
| No | 94 | 66.4 (6.2) | 175 | 47.9 (3.3) | 30 | 27.2 (7.1) | - | - | - | - | |
| MEC visit timing | Winter | 61 | 31.2 (6.5) | 126 | 36.0 (5.3) | 39 | 37.6 (5.8) | - | - | - | - |
| Summer | 71 | 68.8 (6.5) | 179 | 64.0 (5.3) | 59 | 62.4 (5.8) | - | - | - | - | |
Data representative of the US population were obtained from the 2009–2012 National Health and Nutrition Examination Surveys (NHANES). The sub-group excluded individuals who were older than 70 years, had not fasted for 8 hours, pregnant or lactating women, individuals who self-reported ever having a diagnosis of diabetes or weak or failing kidneys, individuals with a measured BMI outside the normal weight range, and individuals with fasting HgA1c ≥ 6.5%, fasting HOMA-IR ≥ 2.5, fasting glucose ≥ 126 mg/dL, fasting triglyceride ≥ 150 mg/dL, fasting HDL < 40 mg/dL for men, HDL < 50 mg/dL for women, and/or estimated glomerular filtration rate (eGFR) < 60. n, Number of individuals who participated in the 2009–2012 NHANES. Weighted %, Represents the weighted proportion of the age group with the row characteristic (Column percent). Activity METs represents physical activity metabolic equivalents. Dietary solute load was calculated from protein, sodium, and potassium intake for the previous day. Prescription medication reflects any prescription medication used in the month before NHANES participation. MEC, Mobile Examination Clinic; Winter timing, Nov–April; Summer timing, May–Oct. Participants that had one or more chronic disease risk factor had a measured BMI outside the normal weight range and/or a measured HgA1c ≥ 6.5%, HOMA-IR ≥ 2.5, fasting glucose ≥ 126 mg/dL, fasting triglyceride ≥150 mg/dL, HDL<40 mg/dL for men, HDL<50 mg/dL for women, and/or CKD-EPI estimated glomerular filtration rate (eGFR) < 60. *Risk factor measurements were only assessed for participants who fasted for 8 hours or longer.